Your browser doesn't support javascript.
loading
RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study.
Mercatali, Laura; Ricci, Marianna; Scarpi, Emanuela; Serra, Patrizia; Fabbri, Francesca; Ricci, Rossana; Liverani, Chiara; Zanoni, Michele; Zoli, Wainer; Maltoni, Roberta; Gunelli, Erica; Amadori, Dino; Ibrahim, Toni.
Affiliation
  • Mercatali L; Osteoncology and Rare Tumors Center, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), via P. Maroncelli 40, 47014 Meldola (FC), Italy. t.ibrahim@irst.emr.it.
Int J Mol Sci ; 14(6): 10683-93, 2013 May 23.
Article in En | MEDLINE | ID: mdl-23702841

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Diphosphonates / RANK Ligand / Receptor Activator of Nuclear Factor-kappa B / Osteoprotegerin / Imidazoles / Antineoplastic Agents Type of study: Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Mol Sci Year: 2013 Document type: Article Affiliation country: Italy Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Diphosphonates / RANK Ligand / Receptor Activator of Nuclear Factor-kappa B / Osteoprotegerin / Imidazoles / Antineoplastic Agents Type of study: Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Mol Sci Year: 2013 Document type: Article Affiliation country: Italy Country of publication: Switzerland